BIOBIJOU Co.,Ltd. (KOSDAQ:489460)

BIOBIJOU Statistics

Total Valuation

BIOBIJOU has a market cap or net worth of KRW 120.81 billion. The enterprise value is 102.50 billion.

Market Cap	120.81B
Enterprise Value	102.50B

Important Dates

The next estimated earnings date is Tuesday, April 7, 2026.

Earnings Date	Apr 7, 2026
Ex-Dividend Date	Dec 29, 2025

Share Statistics

BIOBIJOU has 15.04 million shares outstanding. The number of shares has increased by 22.11% in one year.

Current Share Class	15.04M
Shares Outstanding	15.04M
Shares Change (YoY)	+22.11%
Shares Change (QoQ)	+0.46%
Owned by Insiders (%)	17.34%
Owned by Institutions (%)	5.84%
Float	3.85M

Valuation Ratios

The trailing PE ratio is 26.95.

PE Ratio	26.95
Forward PE	n/a
PS Ratio	4.24
PB Ratio	1.95
P/TBV Ratio	1.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.49, with an EV/FCF ratio of -32.86.

EV / Earnings	24.69
EV / Sales	3.60
EV / EBITDA	20.49
EV / EBIT	24.25
EV / FCF	-32.86

Financial Position

The company has a current ratio of 30.20, with a Debt / Equity ratio of 0.01.

Current Ratio	30.20
Quick Ratio	20.97
Debt / Equity	0.01
Debt / EBITDA	0.07
Debt / FCF	-0.12
Interest Coverage	110.65

Financial Efficiency

Return on equity (ROE) is 8.94% and return on invested capital (ROIC) is 9.03%.

Return on Equity (ROE)	8.94%
Return on Assets (ROA)	5.20%
Return on Invested Capital (ROIC)	9.03%
Return on Capital Employed (ROCE)	6.80%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.56
Inventory Turnover	2.20

Taxes

In the past 12 months, BIOBIJOU has paid 846.93 million in taxes.

Income Tax	846.93M
Effective Tax Rate	16.94%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	10,695.40
200-Day Moving Average	14,492.70
Relative Strength Index (RSI)	36.49
Average Volume (20 Days)	56,427

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIOBIJOU had revenue of KRW 28.49 billion and earned 4.15 billion in profits. Earnings per share was 298.00.

Revenue	28.49B
Gross Profit	15.88B
Operating Income	4.23B
Pretax Income	5.00B
Net Income	4.15B
EBITDA	5.00B
EBIT	4.23B
Earnings Per Share (EPS)	298.00

Balance Sheet

The company has 18.70 billion in cash and 373.54 million in debt, with a net cash position of 18.32 billion or 1,217.97 per share.

Cash & Cash Equivalents	18.70B
Total Debt	373.54M
Net Cash	18.32B
Net Cash Per Share	1,217.97
Equity (Book Value)	61.98B
Book Value Per Share	4,099.58
Working Capital	46.06B

Cash Flow

In the last 12 months, operating cash flow was -2.77 billion and capital expenditures -348.76 million, giving a free cash flow of -3.12 billion.

Operating Cash Flow	-2.77B
Capital Expenditures	-348.76M
Depreciation & Amortization	774.43M
Net Borrowing	-2.40B
Free Cash Flow	-3.12B
FCF Per Share	-207.37

Margins

Gross margin is 55.73%, with operating and profit margins of 14.84% and 14.57%.

Gross Margin	55.73%
Operating Margin	14.84%
Pretax Margin	17.55%
Profit Margin	14.57%
EBITDA Margin	17.56%
EBIT Margin	14.84%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 1.28%.

Dividend Per Share	100.00
Dividend Yield	1.28%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-22.11%
Shareholder Yield	-20.83%
Earnings Yield	3.44%
FCF Yield	-2.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIOBIJOU has an Altman Z-Score of 85.22 and a Piotroski F-Score of 4.

Altman Z-Score	85.22
Piotroski F-Score	4